FDA declares the shortage of obesity drug Zepbound has ended. SCOTT SIMON, HOST: The drug Zepbound might not have the same name recognition as Ozempic, but it's another in the class to treat obesity and Type 2 diabetes. The compounders said there was no way the shortage could be over, because many patients still couldn't fill their name-brand prescriptions, and …
Consultations for obesity drug prescriptions are way up over 2023, survey finds Appointments with health professionals for obesity drug consultations are way up, according to data from Zocdoc, a provider of scheduling services. SYDNEY LUPKIN, BYLINE: Doctor Sarah Nosal, a family physician in the South Bronx, New York, says a lot more of her patients have come in asking about …
The FDA approves a new type of schizophrenia drug The Food and Drug Administration, as expected, approved KarXT, the first new type of drug for schizophrenia in decades. AILSA CHANG, HOST: Today, the Food and Drug Administration approved the first new type of drug for schizophrenia in decades. LUPKIN: Since the first antipsychotic drug was introduced in the 1950s, the …
9 Companies Pledge Not To Submit Coronavirus Vaccine To FDA Until It's Proved Safe To reassure the public, nine companies issued a joint statement Tuesday saying they won't seek government approval for their coronavirus vaccines until full safety and effectiveness data are in hand. SYDNEY LUPKIN, BYLINE: Drugmakers are pledging not to submit their vaccines for FDA review unless large …
